arrow
M

Manuel Zamparini

university of brescia
H指数:14
被引数:610

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Cemiplimab in cutaneous squamous cell carcinoma: a longer follow-up study focusing on the late toxicities

西米普利单抗在皮肤鳞状细胞癌中的应用:一项关注晚期毒性的长期随访研究

2026-09-060
PRE
Impact of baseline nutritional and inflammatory markers on safety and efficacy of immune checkpoint inhibitors in cancer patients: a retrospective, monocentric study

癌症患者基线营养和炎症标志物对免疫检查点抑制剂安全性和有效性的影响:一项回顾性、单中心研究

2026-04-280
OAAI
A prospective study with Comprehensive Geriatric Assessment (CGA) before curative treatment in older patients with locally advanced head and neck squamous cell carcinoma (LA-HNSCC)

一项在局部晚期头颈鳞状细胞癌(LA-HNSCC)老年患者根治性治疗前进行综合老年评估(CGA)的前瞻性研究

2026-04-070
PRE
Working alliance, daily activities, and emotions in patients with schizophrenia spectrum disorders and treating staff: a study with the experience sampling method

精神分裂症谱系障碍患者和治疗人员的工作联盟,日常活动和情绪: 经验抽样方法的研究

2025-12-010
PREAI
A multicenter retrospective analysis of recurrent/metastatic nasopharyngeal cancer from non-endemic areas: results in the pre-immunotherapy era

非流行区复发性/转移性鼻咽癌的多中心回顾性分析:免疫治疗时代前的结果

2025-09-020
PRE
Needs for care of residents with schizophrenia spectrum disorders and association with daily activities and mood monitored with experience sampling method: the DIAPASON study ( vol 32 , e18 , 2023)

精神分裂症谱系障碍患者护理需求及其与日常活动和情绪(通过经验取样法监测)的关系:DIAPASON研究(第32卷,e18,2023年)

2025-07-010
OA
Total and Regional Changes in Body Composition in Metastatic Hormone-sensitive Prostate Cancer Patients Randomized to Receive Androgen Deprivation + Enzalutamide ± Zoledronic Acid. The BONENZA Study

转移性激素敏感性前列腺癌患者接受雄激素剥夺+恩扎卢amide±唑来膦酸治疗后的全身及区域性体成分变化。BONENZA研究

2025-06-010
OAAI
Body composition in early breast cancer patients treated with adjuvant aromatase inhibitors: Does dietary counseling matter?

接受芳香化酶抑制剂辅助治疗的早期乳腺癌患者的身体成分: 饮食咨询重要吗?

BREAST
IF7.9
2024-12-010
OAAI
Adverse skeletal related events in patients with bone-metastatic pheochromocytoma/paraganglioma
2024-09-012
PRE
Total and regional changes in body composition in metastatic hormone-sensitive prostate cancer (mHSPC) patients randomized to receive androgen deprivation plus enzalutamide plus /- zoledronic acid: The BonEnza study

转移性激素敏感性前列腺癌(mHSPC)患者接受雄激素剥夺联合恩扎卢胺联合/不联合唑来膦酸治疗后的全身及区域身体成分变化:BonEnza研究

2024-09-010
PRE